|Title||Accurate circular consensus long-read sequencing improves variant detection and assembly of a human genome.|
|Publication Type||Journal Article|
|Year of Publication||2019|
|Authors||Wenger, AM, Peluso, P, Rowell, WJ, Chang, P-C, Hall, RJ, Concepcion, GT, Ebler, J, Fungtammasan, A, Kolesnikov, A, Olson, ND, Töpfer, A, Alonge, M, Mahmoud, M, Qian, Y, Chin, C-S, Phillippy, AM, Schatz, MC, Myers, G, DePristo, MA, Ruan, J, Marschall, T, Sedlazeck, FJ, Zook, JM, Li, H, Koren, S, Carroll, A, Rank, DR, Hunkapiller, MW|
|Date Published||2019 Oct|
|Keywords||Base Sequence, DNA, Circular, Genetic Variation, Genome, Human, Haplotypes, High-Throughput Nucleotide Sequencing, Humans, Sequence Analysis, DNA|
The DNA sequencing technologies in use today produce either highly accurate short reads or less-accurate long reads. We report the optimization of circular consensus sequencing (CCS) to improve the accuracy of single-molecule real-time (SMRT) sequencing (PacBio) and generate highly accurate (99.8%) long high-fidelity (HiFi) reads with an average length of 13.5 kilobases (kb). We applied our approach to sequence the well-characterized human HG002/NA24385 genome and obtained precision and recall rates of at least 99.91% for single-nucleotide variants (SNVs), 95.98% for insertions and deletions 15 megabases (Mb) and concordance of 99.997%, substantially outperforming assembly with less-accurate long reads.
|Alternate Journal||Nat Biotechnol|
|PubMed Central ID||PMC6776680|
|Grant List||R01 HG006677 / HG / NHGRI NIH HHS / United States |
R01 HG010040 / HG / NHGRI NIH HHS / United States
Accurate circular consensus long-read sequencing improves variant detection and assembly of a human genome.
|Deleterious heteroplasmic mitochondrial mutations are associated with an increased risk of overall and cancer-specific mortality. Nat Commun. 2023;14(1):6113..|
|PLS3 missense variants affecting the actin-binding domains cause X-linked congenital diaphragmatic hernia and body-wall defects. Am J Hum Genet. 2023;110(10):1787-1803..|
|Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer. Front Immunol. 2023;14:1188831..|